智通财经APP获悉，CXO概念股跌幅居前，截至发稿，昭衍新药(06127)跌5.82%，报21.7港元；康龙化成(03759)跌3.65%，报21.1港元；泰格医药(03347)跌3.02%，报42.46港元。
消息面上，IMF总裁格奥尔基耶娃表示，如果中东战争引发的能源价格冲击长期持续，各国央行必须做好准备收紧货币政策，以防止出现通胀螺旋式上升；但与此同时，央行也需要密切关注经济需求是否出现疲软迹象，从而避免不必要的利率上调。
中信建投发布研报称，海外投融资大环境进入季度间波动，不同阶段、不同疾病领域的CXO服务需求进一步分化，国内投融资活动景气度持续上行，弹性更强，持续看好CXO板块成长空间。AI对制药及医药外包行业影响短期有限、但市场对新技术对长期的行业发展变革的影响已初步达成共识，早期研发阶段(CRO)影响呈分化趋势，生产段(D、M)整体利好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.